The drug has got off to a flying start in the US ... UK market access Peter Kuiper, general manager UK & Ireland at Sanofi Genzyme said the European Commission approval of Dupixent was a ...
Two years previously, TKT signed an exclusive licensing agreement with Genzyme Corporation to market Elaprase (idursulfase), which is a drug used to treat Hunter syndrome (also called MPS-II), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback